JP2007518685A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518685A5
JP2007518685A5 JP2006519266A JP2006519266A JP2007518685A5 JP 2007518685 A5 JP2007518685 A5 JP 2007518685A5 JP 2006519266 A JP2006519266 A JP 2006519266A JP 2006519266 A JP2006519266 A JP 2006519266A JP 2007518685 A5 JP2007518685 A5 JP 2007518685A5
Authority
JP
Japan
Prior art keywords
alkyl
cyclo
aryl
hydroxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006519266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518685A (ja
JP4642021B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/011864 external-priority patent/WO2005013928A1/en
Publication of JP2007518685A publication Critical patent/JP2007518685A/ja
Publication of JP2007518685A5 publication Critical patent/JP2007518685A5/ja
Application granted granted Critical
Publication of JP4642021B2 publication Critical patent/JP4642021B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006519266A 2003-08-12 2004-08-12 育毛を促進する組成物および方法 Expired - Fee Related JP4642021B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49412103P 2003-08-12 2003-08-12
PCT/JP2004/011864 WO2005013928A1 (en) 2003-08-12 2004-08-12 Composition and method for promoting hair growth

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010226217A Division JP5318837B2 (ja) 2003-08-12 2010-10-06 育毛を促進する組成物および方法

Publications (3)

Publication Number Publication Date
JP2007518685A JP2007518685A (ja) 2007-07-12
JP2007518685A5 true JP2007518685A5 (enExample) 2007-10-04
JP4642021B2 JP4642021B2 (ja) 2011-03-02

Family

ID=34135320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006519266A Expired - Fee Related JP4642021B2 (ja) 2003-08-12 2004-08-12 育毛を促進する組成物および方法
JP2010226217A Expired - Fee Related JP5318837B2 (ja) 2003-08-12 2010-10-06 育毛を促進する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010226217A Expired - Fee Related JP5318837B2 (ja) 2003-08-12 2010-10-06 育毛を促進する組成物および方法

Country Status (15)

Country Link
US (2) US8686035B2 (enExample)
EP (2) EP1673058B1 (enExample)
JP (2) JP4642021B2 (enExample)
KR (3) KR101166738B1 (enExample)
CN (1) CN1867310B (enExample)
AT (1) ATE526008T1 (enExample)
CA (1) CA2534645C (enExample)
CY (1) CY1112076T1 (enExample)
DK (1) DK1673058T3 (enExample)
ES (1) ES2369892T3 (enExample)
PL (1) PL1673058T3 (enExample)
PT (1) PT1673058E (enExample)
SI (1) SI1673058T1 (enExample)
TW (2) TWI495471B (enExample)
WO (1) WO2005013928A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI495471B (zh) 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
EP1830793A1 (en) * 2004-12-29 2007-09-12 R-Tech Ueno, Ltd. Composition and method for scalp and hair treatment
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7964596B2 (en) * 2008-03-07 2011-06-21 Allergan, Inc. Therapeutic compounds
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
RU2500674C2 (ru) * 2008-05-09 2013-12-10 Аллерган, Инк. Терапевтические соединения
JP5850862B2 (ja) * 2010-02-24 2016-02-03 アドヴァンジェン・インターナショナル・プロプライアタリー・リミテッド 脱毛の治療もしくは予防または毛の成長の促進のための方法
JPWO2012176792A1 (ja) * 2011-06-21 2015-02-23 株式会社アールテック・ウエノ 炎症性疾患、アレルギー性疾患および自己免疫疾患用途のための医薬組成物
WO2014182908A1 (en) * 2013-05-10 2014-11-13 Topical Solutions, Inc. Compositions and methods for treating nails, claws, and hoofs
KR20220044248A (ko) 2019-08-07 2022-04-07 아네이라 파마, 인코포레이티드 탈모의 치료를 위한 방법 및 조성물

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
DE2434133C2 (de) * 1974-07-12 1987-03-19 Schering AG, 1000 Berlin und 4709 Bergkamen 15,15-Äthylendioxy-Prostansäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CS230650B1 (cs) 1983-01-14 1984-08-13 Jan Stanek Způsob výroby acetalů prostanoidů
DE3325175A1 (de) 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPS61218510A (ja) * 1985-03-22 1986-09-29 Dai Ichi Seiyaku Co Ltd 毛髪用剤
US5428062A (en) * 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5591887A (en) * 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5166178B1 (en) * 1987-09-18 1998-07-21 R Tech Ueno Ltd Ocular hypotensive agents
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
DE69106777T2 (de) * 1990-05-22 1995-05-18 Ueno Seiyaku Oyo Kenkyujo Kk Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
US5175189A (en) * 1990-05-22 1992-12-29 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination for ophthalmic use
EP0458590B1 (en) * 1990-05-22 1996-01-10 R-Tech Ueno Ltd. Treatment of ocular hypertention with a synergistic combination
TW210287B (enExample) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
US5274130A (en) * 1991-09-03 1993-12-28 R-Tech Ueno Ltd. Process for production of prostaglandin intermediates
ATE207360T1 (de) * 1992-03-19 2001-11-15 R Tech Ueno Ltd Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
EP0668076B1 (en) * 1992-08-26 2002-09-04 Sucampo AG Stabilization of a prostanoic acid compound
SE9303444D0 (sv) 1993-10-20 1993-10-20 Kabi Pharmacia Ab New use of prostaglandins
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
JP3187438B2 (ja) * 1996-06-10 2001-07-11 株式会社アールテック・ウエノ エンドセリン拮抗剤
AU3588797A (en) * 1996-07-03 1998-01-21 Board Of Regents Of The University Of Oklahoma, The Enhancement of skin pigmentation by prostaglandins
WO1998020881A1 (en) * 1996-11-12 1998-05-22 Alcon Laboratories, Inc 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
DE69823852T2 (de) * 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
JP3217293B2 (ja) * 1997-04-17 2001-10-09 株式会社アールテック・ウエノ 発毛・育毛剤
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6225348B1 (en) * 1998-08-20 2001-05-01 Alfred W. Paulsen Method of treating macular degeneration with a prostaglandin derivative
EP1220849B1 (en) * 1999-10-15 2004-05-19 Sucampo AG Bicyclic compounds composition and method for stabilizing the same
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
EP1420794B1 (en) 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
JP2003155218A (ja) * 2001-09-10 2003-05-27 Lion Corp 養育毛組成物
US7351404B2 (en) * 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US20030199590A1 (en) * 2002-07-25 2003-10-23 Cagle Gerald D Prostaglandin analogues for promotion of hair growth
US20040115234A1 (en) * 2002-09-24 2004-06-17 Gewirtz Joan T. Cosmetic composition
TWI495471B (zh) 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
EP1830793A1 (en) * 2004-12-29 2007-09-12 R-Tech Ueno, Ltd. Composition and method for scalp and hair treatment
KR101396731B1 (ko) * 2005-03-31 2014-05-19 산텐 세이야꾸 가부시키가이샤 프로스타글란딘 Ｆ２ａ 유도체를 유효 성분으로서 함유하는망막신경세포 보호제
WO2007023841A1 (ja) 2005-08-25 2007-03-01 Taisho Pharmaceutical Co., Ltd. 発毛剤組成物
US20070160562A1 (en) * 2006-01-06 2007-07-12 Brinkenhoff Michael C Delivery devices for hair-promoting cosmetic agent
US20070286890A1 (en) * 2006-06-07 2007-12-13 John Garnett Walt Eyelash applicator and method
US8206695B2 (en) * 2007-04-26 2012-06-26 La Canada Ventures, Inc. Eyelash enhancement composition and method of treatment
US20090018204A1 (en) * 2007-07-13 2009-01-15 Brinkenhoff Michael C Composition and method for enhancing hair growth
WO2009035565A1 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Prostaglandin analogues for implant devices and methods
US20090088473A1 (en) * 2007-09-28 2009-04-02 Cayman Chemical Company Method for screening of prostaglandin compounds comprising an optimal formulation for the enhancement of hair growth and the stimulation of follicular anagen and formulations resulting therefrom
WO2009054787A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5
US7649021B2 (en) * 2007-10-31 2010-01-19 Meta Cosmetics, Llc Prostaglandin analog compositions to treat epithelial-related conditions
AU2009246330B2 (en) 2008-05-14 2015-04-02 Peter Thomas Roth Labs, Llc Prostaglandin based compositions and method of use thereof
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss

Similar Documents

Publication Publication Date Title
JP2004527567A5 (enExample)
CA2600331A1 (en) Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
JP4044967B2 (ja) １１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
JP2007518685A5 (enExample)
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
HRP20090250T1 (hr) Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze
JPWO1998034916A1 (ja) １１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
JP2009513753A5 (enExample)
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
JP2013518832A5 (enExample)
JP2005526097A5 (enExample)
JP2012502048A5 (enExample)
AR110149A2 (es) Composición catártica
JP2014505723A5 (enExample)
JP2010090149A5 (enExample)
JP2006513232A5 (enExample)
RU2012119778A (ru) Водная композиция
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JP2006506381A5 (enExample)
JP2004519412A5 (enExample)
JP2004529960A5 (enExample)
JP2010533707A5 (enExample)
RU2008100587A (ru) Применение санглиферина для лечения вируса гепатита с
JP2006518765A5 (enExample)
JP2008528440A5 (enExample)